120 related articles for article (PubMed ID: 9865471)
1. Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy.
Tanaka H; Waga S; Yokoyama M
Tohoku J Exp Med; 1998 Aug; 185(4):247-52. PubMed ID: 9865471
[TBL] [Abstract][Full Text] [Related]
2. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Shima Y; Nakanishi K; Kamei K; Togawa H; Nozu K; Tanaka R; Sasaki S; Iijima K; Yoshikawa N
Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
[TBL] [Abstract][Full Text] [Related]
3. Validity of the Oxford classification of IgA nephropathy in children.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Togawa H; Hashimura Y; Kaito H; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2012 May; 27(5):783-92. PubMed ID: 22134880
[TBL] [Abstract][Full Text] [Related]
4. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
Furuse A; Hiramatsu M; Adachi N; Karashima S; Hattori S; Matsuda I
Int J Pediatr Nephrol; 1985; 6(3):205-8. PubMed ID: 4055239
[TBL] [Abstract][Full Text] [Related]
5. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Yoshikawa N; Ito H; Sakai T; Takekoshi Y; Honda M; Awazu M; Ito K; Iitaka K; Koitabashi Y; Yamaoka K; Nakagawa K; Nakamura H; Matsuyama S; Seino Y; Takeda N; Hattori S; Ninomiya M
J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
[TBL] [Abstract][Full Text] [Related]
6. IgA nephropathy in a patient with unilateral renal agenesis.
Waga S; Kakizaki Y; Sugimoto K; Tanaka H; Yokoyama M
Nephron; 1996; 74(2):479-80. PubMed ID: 8893200
[No Abstract] [Full Text] [Related]
7. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
Iitaka K; Yamamoto A; Ogawa N; Sekine T; Tamai S; Motoyama O
Clin Exp Nephrol; 2003 Dec; 7(4):284-9. PubMed ID: 14712358
[TBL] [Abstract][Full Text] [Related]
8. Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy.
Kuriki M; Asahi K; Asano K; Sakurai K; Eiro M; Suzuki H; Watanabe K; Katoh T; Watanabe T
Nephrol Dial Transplant; 2003 Jul; 18(7):1311-5. PubMed ID: 12808167
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Shima Y; Nakanishi K; Kaku Y; Ishikura K; Hataya H; Matsuyama T; Honda M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N;
Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
[TBL] [Abstract][Full Text] [Related]
10. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
11. Repeat renal biopsy in children with IgA nephropathy.
Yoshikawa N; Iijima K; Matsuyama S; Suzuki J; Kameda A; Okada S; Nakamura H
Clin Nephrol; 1990 Apr; 33(4):160-7. PubMed ID: 2190720
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
Tanaka H; Suzuki K; Nakahata T; Tsugawa K; Konno Y; Tsuruga K; Ito E; Waga S
Pediatr Int; 2004 Oct; 46(5):576-9. PubMed ID: 15491387
[TBL] [Abstract][Full Text] [Related]
13. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
14. Glomerular morphometry of twenty-three biopsied patients with IgA nephropathy.
Biondo B; Grosso E; Fogato E; Giordano F; Matturri L
Am J Nephrol; 1995; 15(2):99-104. PubMed ID: 7733163
[TBL] [Abstract][Full Text] [Related]
15. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy.
Shoji T; Nakanishi I; Suzuki A; Hayashi T; Togawa M; Okada N; Imai E; Hori M; Tsubakihara Y
Am J Kidney Dis; 2000 Feb; 35(2):194-201. PubMed ID: 10676716
[TBL] [Abstract][Full Text] [Related]
16. Association of angiotensin-converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy.
Asano T; Tatsuma N; Yoshida J; Ohashi R; Ambo K; Tsuchiya M; Murakami M; Yamanaka N; Honda M; Yamamoto M
Clin Nephrol; 1999 Jun; 51(6):335-40. PubMed ID: 10404693
[TBL] [Abstract][Full Text] [Related]
17. IgA nephropathy in children with minimal proteinuria: to biopsy or not to biopsy?
Cambier A; Roy JP; Dossier C; Patey N; Rabant M; Boyer O; Delbet JD; Lapeyraque AL; Hogan J
Pediatr Nephrol; 2024 Mar; 39(3):781-787. PubMed ID: 37698655
[TBL] [Abstract][Full Text] [Related]
18. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
[TBL] [Abstract][Full Text] [Related]
19. IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA.
Andreoli SP; Yum MN; Bergstein JM
Am J Nephrol; 1986; 6(1):28-33. PubMed ID: 3515942
[TBL] [Abstract][Full Text] [Related]
20. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
Kawasaki Y; Maeda R; Ohara S; Suyama K; Hosoya M
Pediatr Int; 2018 Feb; 60(2):162-167. PubMed ID: 29178575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
